肿瘤血栓临床研究-.pptVIP

  • 1
  • 0
  • 约2.56万字
  • 约 39页
  • 2026-10-22 发布于重庆
  • 举报

*Intheapriorispecifiedsubgroupofpatientswithalifeexpectancyofsixmonthsoraboveatenrolment,thehazardratioformortalitywas0.64,withamediansurvivalof15.4and9.4monthsintheFraxiparine?andplacebogroups,respectively.Inpatientswithashorterlifeexpectancy,thehazardratioofmortalitywas0.88(95%CI:0.62to1.25).**Gemcitabine(GEM)andcisplatinum(CDDP)areactivedrugsinadvancedpancreaticcancer.ThispilotstudywasperformedbetweenNovember1999andJuly2002toassesstheeffectsofaddingFraxiparine?(0.3mLod)totheGEMplusCDDP

文档评论(0)

1亿VIP精品文档

相关文档